(Total Views: 587)
Posted On: 02/06/2025 8:42:27 AM
Post# of 157757
Re: HHIGambler #149898
“including opportunities that might explore the potential widespread applications for leronlimab as a treatment path for fibrosis in other organs.”
Do we know of any drugs that are capable of reducing fibrosis or reversing it? Seems pretty incredible.
Do we know of any drugs that are capable of reducing fibrosis or reversing it? Seems pretty incredible.
(4)
(0)
Daniel Rizzo
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
https://firegatebiotech.com/2025
https://zenodo.org/records/17291133?token=eyJ...kN7msthgMA
— Jeremiah 51:36
Founder & CEO | FireGate Biotech™
AI Platform: Lux Veritas™
Federal Whistleblower Case References
• HHS & SEC Whistleblower ID – HL-1412396
• DOJ Investigation Report / Whistleblower ID – 20250705-0001
• NIH Case Reference – CS1137565 ( IC IG / 50 U.S.C. § 3033 )
Website: FireGateBiotech.com
(For official updates and correspondence — I will no longer be posting here or responding via DMs)
Contact FireGate Biotech
Principal Investigator:
FG001|FG002|FG003
https://zenodo.org/records/17290045?token=eyJ...UkeT_EvKIQ
https://firegatebiotech.com/2025
https://zenodo.org/records/17291133?token=eyJ...kN7msthgMA
— Jeremiah 51:36
